publication venue for
- Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register. 1-7. 2024
- Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER). . 1-6. 2024
- Prevalence Of Crystal Deposits In Asymptomatic Hyperuricemia According To Different Scanning Definitions: A Comparative Study. 152470-152476. 2024
- Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER). . 1-9. 2023
- Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients. 0-6. 2021
- Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).. 657-662. 2020
- Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice. 126-135. 2019
- Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.. 22-27. 2018
- Incidence, associated factors and clinical impact of severe infections in a large multicentric cohort of patients with Systemic Lupus Erythematosus. 2017
- Gout mimicking rheumatoid arthritis. 28-28. 2016
- Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients. 1-29. 2015
- Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review. 524-533. 2011